Pharmafile Logo
Pharmafocus logo
Advanced Search

Manufacturing and Production

Showing 15 posts of 5811 posts found.

MGC Pharma receives patent protection for epilepsy drug

May 10, 2022 Manufacturing and Production

MGC Pharmaceuticals said a patent had been granted, protecting its unique system used to deliver a cannabis-derived drug being developed …
News

Fourth-dose COVID-19 jab demonstrates good boost

May 10, 2022 Manufacturing and Production

A UK trial has revealed that fourth-dose COVID-19 booster vaccines increase protection against the disease, particularly those aged over 70. …
News

NIH discovery could advance precise therapies for blinding diseases

May 10, 2022 Manufacturing and Production

Research at the National Institutes of Health (NIH) have identified distinct differences among the cells comprising a tissue in the …
News

Jyseleca recommended by HSE for treatment of ulcerative colitis in Ireland

May 3, 2022 Manufacturing and Production

Galapagos Biotech LTD has announced that further to approval from the Health Service Executive (HSE), eligible patients in Ireland will …
News

EU plans to cut unneeded medical tests with data health plan

May 3, 2022 Manufacturing and Production

The EC has announced plans to make health data easier to access for patients, medics, regulators, and researchers, to improve …
News

FDA approve first nonstimulant ADHD med for adults in two decades

May 3, 2022 Manufacturing and Production

The FDA has expanded the indication of Supernus’s Qelbree to patients aged 18 and older, marking the drug as the …
News

EC approves Cabotemyx as second-line treatment for thyroid cancer patients

May 3, 2022 Manufacturing and Production

The EC has approved the use of Cabotemyx (cabozantinib) as a monotherapy for the treatment of adult patients with locally …
News

UK study finds raising frequency of COPD flare ups increases risk of death

April 26, 2022 Manufacturing and Production

The EXACOS UK study in Chronic Obstructive Pulmonary Disease (COPD), funded by AstraZeneca, has shown that an increasing frequency of …
News

FDA approves first COVID-19 treatment for young children

April 26, 2022 Manufacturing and Production

The FDA has expanded the approval of the COVID-19 treatment, Veklury (remdesivir), to include pediatric patients 28 days of age …
News

AstraZeneca drug granted FDA Priority Review

April 19, 2022 Manufacturing and Production

AstraZeneca and Daiichi Sankyo have announced that the lung cancer antibody drug conjugate, Enhertu, has received Priority Review from the …
News

FDA accept New Drug Application for GSK’s daprodustat

April 19, 2022 Manufacturing and Production

GSK has announced the FDA has accepted the New Drug Application (NDA) for daprodustat, an oral hypoxia-inducible factor prolyl hydroxylase …
News

Tjaopack announces completion of Netherlands facility expansion

April 12, 2022 Manufacturing and Production

Tjaopack has announced the completion of its expansion plans, following a €10 million plus investment, at its Etten-Leur facility in …
News

Amid growing fears of antimicrobial-resistance, NHS payment scheme aims for pharma to tackle superbugs

April 12, 2022 Manufacturing and Production

NICE has shared that cefiderocol, and ceftazidime/avibactam, have the potential to save lives. The two medications, which fight drug-resistant superbugs, …
News

VR solution for personalised treatment and surgery guidance to spine surgeons

April 12, 2022 Manufacturing and Production

Seymourpowell and Axis Spine Technologies have announced a virtual reality (VR) solution allowing surgeons to evaluate and develop spinal implants …
News
shutterstock_187433765_16

European Commission approves treatment of unresectable uveal melanoma

April 5, 2022 Manufacturing and Production

Immunocore Holdings has announced that the European Commission has approved KIMMTRAK® (tebentafusp) for the treatment of HLA-A*02:01-positive adult patients with …
News

Latest content

GSK pledges £45m to Fleming Initiative to fight AMR

May 16, 2024

NeuroSense partners with PhaseV on upcoming phase 3 ALS trial

May 16, 2024

AstraZeneca adds new heart failure target through collaboration with BenevolentAI

May 15, 2024

FDA approves Roche’s HPV self-collection screening option

May 15, 2024

NHS accepts Pfizer’s tafamidis for ATTR-CM treatment

May 14, 2024